Table 2

 HPV and p53 codon 72 genotype distribution in normal controls and patients with cervical carcinoma at different histological stages

Cytology/HistologyNHPV-16+HPV-18+p53 Arg /Argp53 Arg/Prop53 Pro/Pro
N, number of individuals analysed.
HPV, human papillomavirus.
Normal9411 (11.7%)6 (6.4%)14 (15.0%)51 (54.2%)29 (30.8%)
Dysplasia31 (33.3%)1 (33.3%)0 (0%)3 (100%)0 (0%)
Cancer stage I+II3922 (56.4%)9 (23.1%)11 (28.2%)20 (51.3%)8 (20.5%)
Cancer stage III+IV1914 (73.7%)5 (26.3%)8 (42.1%)7 (36.8%)4 (21.1%)